Sun 8/19/2018 08:20 ET
DJIA25326.167.660.03%TELCO168.770.590.35%GOLD1191.807.750.65%Shanghai2668.9735.761.34%
S&P 5002850.139.410.33%BANKS487.580.880.18%OIL65.910.450.68%BITCOIN6531.3759.440.91%
NASDAQ7816.3310.160.13%PHARM568.065.741.01%US/EU1.170.000.26%Futures2830.7523.000.81%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Immunomedics - IMMU   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add IMMU
  
From: singhtelecom (Rep: 959) reply to singhtelecomDate: 05/16/2018 22:16
Forum: Immunomedics - Msg #944Thread #674006374 (Rec: 0)
HE KNEW this great news Re: 1,600 June 20 calls bought from 1.30-1.35 above open interest of 212 contract...

reports 'positive' data for sacituzumab govitecan, its metastatic breast cancer drug (19.51 +0.73)
Co announces that sacituzumab govitecan, its lead investigational ADC, induced promising objective responses as a single agent in heavily pre-treated patients with estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative metastatic breast cancer.

Sacituzumab govitecan treatment was generally well tolerated, with no treatment-related deaths. Consistent with safety data obtained in metastatic TNBC, grade 3 or 4 toxicity with greater than 10 percent frequency included neutropenia and leukopenia. There was one case of grade 3/4 diarrhea and febrile neutropenia.



Reply to singhtelecom - Msg #941 - 05/01/2018 10:25


1,600 June 20 calls bought from 1.30-1.35 above open interest of 212 contracts. Stock 18.21. EPS *estimated* 5/9 after close.
What would you like to do? Message: Endorse | Bookmark | Report AbuseUser singhtelecom: Reward | Watch | IgnoreIMMU: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add IMMU
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.